Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Other Accumulated Expenses (2016 - 2026)

SANUWAVE Health has reported Other Accumulated Expenses over the past 16 years, most recently at $5000.0 for Q1 2026.

  • Quarterly Other Accumulated Expenses fell 86.11% to $5000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Mar 2026, down 86.11% year-over-year, with the annual reading at $7000.0 for FY2025, 78.79% down from the prior year.
  • Other Accumulated Expenses was $5000.0 for Q1 2026 at SANUWAVE Health, down from $7000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $1.1 million in Q1 2023 and troughed at $5000.0 in Q1 2026.
  • The 5-year median for Other Accumulated Expenses is $213000.0 (2022), against an average of $347750.0.
  • Year-over-year, Other Accumulated Expenses skyrocketed 3243.33% in 2023 and then tumbled 98.4% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $319000.0 in 2022, then soared by 196.87% to $947000.0 in 2023, then crashed by 96.52% to $33000.0 in 2024, then tumbled by 78.79% to $7000.0 in 2025, then fell by 28.57% to $5000.0 in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Other Accumulated Expenses are $5000.0 (Q1 2026), $7000.0 (Q4 2025), and $6000.0 (Q3 2025).